Patents - Global Data - Dimensions
Patent-family-91448941
Applicants:
- Debiotech (Switzerland) [NORA names: Switzerland; Europe, Non-EU; OECD]
- Jian Mabao
- Debiotech SA
Abstract
The present invention relates to a method for reducing or preventing tumor progression or treating cancer in a subject, the method comprising administering to the subject a binding agent comprising a first antigen binding region that binds to human CD137 and a second antigen binding region that binds to human PD-L1. The invention also provides binding agents for use in reducing or preventing tumor progression or for use in the treatment of cancer.
Patent Family Records (1)
Combination dosage regimen of CD137 and PD-L1 binding agent
Debiotech (Switzerland), Debiotech SA, Jian Mabao U. Sassin, A. Muik, U. Forsman, (...more)
2024, CN-118215678-A
